Miriame Victor - PerkinElmer Chief Commercial Officer, Senior Vice President
| PKIDelisted Stock | USD 115.24 0.74 0.64% |
Insider
Miriame Victor is Chief Commercial Officer, Senior Vice President of PerkinElmer since 2021.
| Age | 42 |
| Tenure | 3 years |
| Phone | 781 663 6900 |
| Web | https://www.perkinelmer.com |
PerkinElmer Management Efficiency
The company has Return on Asset of 0.0369 % which means that on every $100 spent on assets, it made $0.0369 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0706 %, implying that it generated $0.0706 on every 100 dollars invested. PerkinElmer's management efficiency ratios could be used to measure how well PerkinElmer manages its routine affairs as well as how well it operates its assets and liabilities.PerkinElmer has 3.92 B in debt with debt to equity (D/E) ratio of 0.65, which is OK given its current industry classification. PerkinElmer has a current ratio of 1.98, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for PerkinElmer to invest in growth at high rates of return.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Judith Seltz | Laboratory of | 58 | |
| Keeley Aleman | Waters | 47 | |
| Ruby Chandy | Thermo Fisher Scientific | 58 | |
| Susan Tousi | Illumina | 55 | |
| Richard Wong | Mettler Toledo International | 59 | |
| Jonathan Pratt | Waters | 54 | |
| Michael Petras | Sotera Health Co | 55 | |
| Kevin Pegels | Illumina | 56 | |
| C Harris | Thermo Fisher Scientific | 64 | |
| Domitille Bigot | Mettler Toledo International | 48 | |
| Belinda Hyde | Waters | 53 | |
| Kevin Kempskie | Waters | N/A | |
| Syed Jafry | Thermo Fisher Scientific | 56 | |
| Joe Cronin | ICON PLC | N/A | |
| Jeffery Chadbourne | IDEXX Laboratories | 48 | |
| Thomas OLeary | ICON PLC | N/A | |
| Michael Biehl | Sotera Health Co | 68 | |
| Paul MD | Laboratory of | 62 | |
| Alexander MD | Illumina | 47 | |
| Victoria Creamer | Charles River Laboratories | 54 | |
| Costa Panagos | IQVIA Holdings | N/A | |
Management Performance
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 |
PerkinElmer Leadership Team
Elected by the shareholders, the PerkinElmer's board of directors comprises two types of representatives: PerkinElmer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PerkinElmer. The board's role is to monitor PerkinElmer's management team and ensure that shareholders' interests are well served. PerkinElmer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PerkinElmer's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joel Goldberg, Senior Vice President - Administration, General Counsel, Secretary | ||
| Samuel Chapin, Independent Director | ||
| Michel Vounatsos, Independent Director | ||
| James Mock, Chief Financial Officer, Senior Vice President | ||
| Sylvie Gregoire, Independent Director | ||
| Andrew Okun, Chief Accounting Officer, Vice President, Treasurer | ||
| Pascale Witz, Independent Director | ||
| Miriame Victor, Chief Commercial Officer, Senior Vice President | ||
| Peter Barrett, Independent Director | ||
| Deborah Butters, Chief Human Resource Officer, Senior Vice President | ||
| Frank Witney, Independent Director | ||
| Alexis Michas, Independent Non-Executive Chairman of the Board | ||
| Stephen Willoughby, VP ESG | ||
| Tajinder Vohra, Senior Vice President Global Operations | ||
| Prahlad Singh, Senior Vice President and President - Diagnostics | ||
| Robert Friel, Chairman, CEO and President and Member of Fin. Committee | ||
| Maxwell Krakowiak, VP CFO | ||
| Masoud Toloue, VP Diagnostics | ||
| Daniel Tereau, Senior Vice President Strategy and Business Development | ||
| Alexandros Michas, Independent Non-Executive Chairman of the Board |
PerkinElmer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PerkinElmer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 22.3 B | |||
| Shares Outstanding | 126.41 M | |||
| Shares Owned By Insiders | 0.26 % | |||
| Shares Owned By Institutions | 86.25 % | |||
| Number Of Shares Shorted | 3.53 M | |||
| Price To Earning | 21.07 X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in PerkinElmer Stock
If you are still planning to invest in PerkinElmer check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PerkinElmer's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |